Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/EBIT

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 37.39-0.150.25-0.25-0.17

What is the latest EV/EBIT ratio of MANKIND PHARMA ?

The latest EV/EBIT ratio of MANKIND PHARMA is 37.39 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202437.39
Mar2023-0.15
Mar20220.25
Mar2021-0.25
Mar2020-0.17

How is EV/EBIT of MANKIND PHARMA Trending?

Years EV/EBIT % Change
Mar2024 37.39
Positive
Mar2023 -0.15
Negative
Mar2022 0.25
Positive
Mar2021 -0.25
Negative
Mar2020 -0.17 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/EBIT ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,123.6 Cr 1.3% -4.8% 9.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,068.0 Cr 1.4% 0.1% 13.9% Stock Analytics
DIVIS LABORATORIES ₹177,105.0 Cr 0.8% 12.3% 47.2% Stock Analytics
CIPLA ₹122,016.0 Cr 2.6% -0.1% 0.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,651.0 Cr 7.8% 12.9% 13.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,942.0 Cr 2.7% -0.6% 14.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.3%

-4.8%

9.3%

SENSEX

2.1%

3.7%

14.3%


You may also like the below Video Courses